$2.51T
Total marketcap
$184.28B
Total volume
BTC 50.06%     ETH 15.90%
Dominance

Moderna MRNA Stock

104.26 USD {{ price }} 0.394804% {{change_pct}}%
Exchange
NasdaqGS
Market Cap
39.83B USD
LOW - HIGH [24H]
103.65 - 107.59 USD
VOLUME [24H]
4.03M USD
{{ volume }}
P/E Ratio
0
Earnings per share
-12.33 USD

Moderna Price Chart

Moderna MRNA Financial and Trading Overview

Moderna stock price 104.26 USD
Previous Close 126.05 USD
Open 126 USD
Bid 0 USD x 900
Ask 0 USD x 800
Day's Range 125.08 - 130.19 USD
52 Week Range 115.03 - 217.25 USD
Volume 3.02M USD
Avg. Volume 3.31M USD
Market Cap 49.55B USD
Beta (5Y Monthly) 1.697464
PE Ratio (TTM) 10.904362
EPS (TTM) -12.33 USD
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est 215.93 USD

MRNA Valuation Measures

Enterprise Value 41.73B USD
Trailing P/E 10.904362
Forward P/E -29.743708
PEG Ratio (5 yr expected) 1.29
Price/Sales (ttm) 3.2903607
Price/Book (mrq) 2.6460648
Enterprise Value/Revenue 2.771
Enterprise Value/EBITDA 8.066

Trading Information

Moderna Stock Price History

Beta (5Y Monthly) 1.697464
52-Week Change 1.52%
S&P500 52-Week Change 20.43%
52 Week High 217.25 USD
52 Week Low 115.03 USD
50-Day Moving Average 134.68 USD
200-Day Moving Average 152.95 USD

MRNA Share Statistics

Avg. Volume (3 month) 3.31M USD
Avg. Daily Volume (10-Days) 2.82M USD
Shares Outstanding 381.21M
Float 344.06M
Short Ratio 5.44
% Held by Insiders 9.60%
% Held by Institutions 68.32%
Shares Short 18.72M
Short % of Float 6.52%
Short % of Shares Outstanding 4.90%

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2022
Most Recent Quarter (mrq) March 31, 2023
Next Fiscal Year End December 31, 2023

Profitability

Profit Margin 31.76%
Operating Margin (ttm) 32.05%
Gross Margin 39.81%
EBITDA Margin 34.35%

Management Effectiveness

Return on Assets (ttm) 11.66%
Return on Equity (ttm) 26.62%

Income Statement

Revenue (ttm) 15.06B USD
Revenue Per Share (ttm) 38.61 USD
Quarterly Revenue Growth (yoy) -69.29%
Gross Profit (ttm) 10.55B USD
EBITDA 5.17B USD
Net Income Avi to Common (ttm) 4.78B USD
Diluted EPS (ttm) 11.92
Quarterly Earnings Growth (yoy) -97.79%

Balance Sheet

Total Cash (mrq) 8.92B USD
Total Cash Per Share (mrq) 23.41 USD
Total Debt (mrq) 1.11B USD
Total Debt/Equity (mrq) 5.87 USD
Current Ratio (mrq) 3.464
Book Value Per Share (mrq) 49.122

Cash Flow Statement

Operating Cash Flow (ttm) 993M USD
Levered Free Cash Flow (ttm) 541.88M USD

Profile of Moderna

Country United States
State MA
City Cambridge
Address 200 Technology Square
ZIP 02139
Phone 617 714 6500
Website https://www.modernatx.com
Industry Biotechnology
Sector(s) Healthcare
Full Time Employees 3900

Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, autoimmune, and cardiovascular diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, respiratory syncytial virus, Endemic HCoV, and hMPV+PIV3 vaccines; latent vaccines comprise cytomegalovirus, epstein-barr virus, herpes simplex virus, varicella-zoster virus, and human immunodeficiency virus vaccines; and public health vaccines consists of Zika and Nipah vaccines. The company also offers systemic secreted and cell surface therapeutics; cancer vaccines, such as personalized cancer, KRAS, and checkpoint vaccines; intratumoral immuno-oncology products; localized regenerative, systemic intracellular, and inhaled pulmonary therapeutics. It has strategic alliances and collaborations with AstraZeneca; Merck; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; Chiesi Farmaceutici S.p.A.; Metagenomi, Inc.; Carisma Therapeutics, Inc.; CytomX Therapeutics; Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; and The Bill & Melinda Gates Foundation. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.

Q&A For Moderna Stock

What is a current MRNA stock price?

Moderna MRNA stock price today per share is 104.26 USD.

How to purchase Moderna stock?

You can buy MRNA shares on the NasdaqGS exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Moderna?

The stock symbol or ticker of Moderna is MRNA.

Which industry does the Moderna company belong to?

The Moderna industry is Biotechnology.

How many shares does Moderna have in circulation?

The max supply of Moderna shares is 382.07M.

What is Moderna Price to Earnings Ratio (PE Ratio)?

Moderna PE Ratio is now.

What was Moderna earnings per share over the trailing 12 months (TTM)?

Moderna EPS is -12.33 USD over the trailing 12 months.

Which sector does the Moderna company belong to?

The Moderna sector is Healthcare.

Moderna MRNA included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
{{ item.name }} {{ item.symbol }} {{ item.price }} {{ item.price_usd }}
{{ item.change_pct }}
{{ item.volume }} {{ item.volume_usd }} {{ item.low }} {{ item.low_usd }} {{ item.high }} {{ item.high_usd }} {{ item.components_count }} {{ item.volume }} {{ item.volume_usd }}
NASDAQ Composite IXIC 16103.45 USD
+0.82
4.52B USD 16094.17 USD 16247.59 USD 4.52B USD
S&P 500 (Yahoo.com) GSPC 5149.42 USD
+0.63
2.4B USD 5145.47 USD 5175.6 USD 2.4B USD
S&P 500 INDEX SPX 5149.42 USD
+0.63
2.39B USD 2.39B USD
US100 NDX 17985.01 USD
+0.99
934.12M USD 17973.09 USD 18124.32 USD 934.12M USD
NASDAQ-100 Reduced Value Index NQX 3597 USD
+0.99
3594.62 USD 3624.87 USD
Stlmt ID NASDAQ 100 XQO 16266.86 USD
-0.45
15738.2 USD 16639.8 USD
NASDAQ Global Buyback Achievers DRBG 2057.48 USD
+0.07
2057.43 USD 2059.1 USD
Nasdaq US Price Setters Index NQPRCE 2590.23 USD
+0.35
2589.18 USD 2601.12 USD
Nasdaq AlphaDEX Multi Cap Growt NQDXUSMLTCG 2568.29 USD
+0.16
2566.7 USD 2581.47 USD
NASDAQ 100 Ex Tech Sector NDXX 5309.52 USD
+0.65
5295.77 USD 5334.4 USD
Nasdaq-100 ESG JPY Index NDXESG07 1799.71 JPY 12.15 USD
+0.89
1798.67 JPY 12.14 USD 1816.58 JPY 12.26 USD
NASDAQ-100 PM Settlement Value XQC 16331.98 USD
+1.13
16331.98 USD 16331.98 USD
NASDAQ 100 Notional Net Total R XNDXNNR 20704.93 USD
+0.99
20691.19 USD 20865.32 USD
NASDAQ Biotechnology NBI 4337.34 USD
-0.65
4335.84 USD 4376.86 USD
NASDAQ HealthCare IXHC 986.88 USD
-0.25
986.44 USD 994.67 USD